|
|
|
貝萊德世界健康科學基金A2
(美元)
| 幣別 |
淨值 |
漲跌 |
漲跌比例 |
日期 |
| 美元 |
45.39 |
1.23 |
2.79% |
2020/04/03 |
|
|
| 2010 |
2011 |
2012 |
2013 |
2014 |
2015 |
2016 |
2017 |
2018 |
2019 |
| 1.59% |
5.46% |
16.89% |
43.09% |
24.40% |
4.56% |
-8.02% |
21.78% |
4.98% |
24.36% |
| 貝萊德世界健康科學基金A2(美元)
基金資料
|
|
●以盡量提高總回報為目標。基金在全球將總資產至少70%投資於從事保健、製藥、 醫學科技及生物科技供應及開發業務公司之股權證券。
●投資經驗豐富的研究團隊。健康醫療研究團隊成立超過半世紀，擁有產業豐富的投資經驗與優異的投資績效。
●掌握健康醫療產業長期投資利機點--全球人口老化、 重大醫學科技突破，以及中國、印度、東歐等快速成長新興市場生活水準提高。
●同時囊括醫療產業中生技、製藥、醫療保險服務與設備4大領域，兼顧防禦與成長。
|
| 日期 |
淨值 |
漲跌比例 |
日期 |
淨值 |
漲跌比例 |
| 2020/04/03 |
45.39 |
2.79% |
2020/03/20 |
42.53 |
2.21% |
| 2020/04/02 |
44.16 |
-1.71% |
2020/03/19 |
41.61 |
0.27% |
| 2020/04/01 |
44.93 |
-1.99% |
2020/03/18 |
41.50 |
-2.33% |
| 2020/03/31 |
45.84 |
0.77% |
2020/03/17 |
42.49 |
-0.21% |
| 2020/03/30 |
45.49 |
2.78% |
2020/03/16 |
42.58 |
-1.87% |
| 2020/03/27 |
44.26 |
0.29% |
2020/03/13 |
43.39 |
-2.30% |
| 2020/03/26 |
44.13 |
4.06% |
2020/03/12 |
44.41 |
-6.68% |
| 2020/03/25 |
42.41 |
3.67% |
2020/03/11 |
47.59 |
-0.17% |
| 2020/03/24 |
40.91 |
3.52% |
2020/03/10 |
47.67 |
0.55% |
| 2020/03/23 |
39.52 |
-7.08% |
2020/03/09 |
47.41 |
-3.95% |
基金績效 (可點按欄位名稱排序)
| 名稱 |
一日 |
一週 |
一個月 |
三個月 |
六個月 |
一年 |
今年以來 |
|
2.79% |
2.55% |
-9.15% |
-11.81% |
1.66% |
0.24% |
-12.05% |
| NBI生技指數 |
-1.19% |
1.64% |
-8.58% |
-10.05% |
7.64% |
-6.26% |
-11.74% |
| 費城藥物指數 |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
| AMEX生技指數 |
-1.25% |
1.63% |
-10.04% |
-11.52% |
5.18% |
-15.36% |
-12.96% |
| MSCI 全球醫療保健指數 (price) |
0.00% |
2.57% |
-7.53% |
-12.61% |
0.53% |
-2.20% |
-13.00% |
| MSCI 製藥指數 (price) |
0.00% |
3.91% |
-5.52% |
-11.21% |
1.10% |
-2.72% |
-11.49% |
| MSCI 生物科技指數 (price) |
0.00% |
5.74% |
-3.58% |
-3.50% |
15.53% |
6.18% |
-4.23% |
|
0.61% |
1.07% |
-8.43% |
-11.96% |
-0.08% |
-3.49% |
-12.42% |
|
0.60% |
1.05% |
-8.51% |
-12.18% |
-0.58% |
-4.45% |
-12.65% |
|
5.01% |
10.52% |
-3.20% |
-7.26% |
13.05% |
5.33% |
-7.26% |
|
-0.49% |
5.79% |
-6.14% |
-11.00% |
4.27% |
-7.31% |
-11.00% |
|
-1.02% |
1.34% |
-6.27% |
-12.02% |
-0.07% |
0.67% |
-11.54% |
|
-0.81% |
1.56% |
-6.80% |
-10.01% |
7.33% |
1.34% |
-10.00% |
|
0.00% |
8.27% |
-5.03% |
-9.08% |
-3.18% |
-5.21% |
-9.08% |
|
0.00% |
8.54% |
-4.80% |
-9.49% |
-0.62% |
-3.42% |
-9.49% |
|
0.03% |
3.27% |
-14.50% |
-21.81% |
-10.84% |
1.33% |
-21.81% |
|
0.73% |
4.19% |
-8.32% |
-12.33% |
-1.23% |
-0.07% |
-11.75% |
|
-1.12% |
-0.07% |
-13.05% |
-13.55% |
8.19% |
-6.89% |
-15.21% |
|
-1.15% |
-0.09% |
-13.17% |
-13.85% |
7.50% |
-8.12% |
-15.51% |
|
-3.13% |
0.22% |
-13.59% |
-18.15% |
-0.87% |
-5.28% |
-18.89% |
|
-1.13% |
0.56% |
-10.29% |
-15.62% |
0.46% |
-6.87% |
-16.40% |
|
-1.12% |
0.53% |
-10.38% |
-15.83% |
-0.04% |
-7.78% |
-16.63% |
|
-1.12% |
0.48% |
-10.72% |
-16.33% |
-1.12% |
-9.83% |
-17.14% |
|
-1.08% |
0.53% |
-10.63% |
-16.15% |
-0.70% |
-9.12% |
-16.95% |
|
-1.11% |
0.60% |
-10.22% |
-15.44% |
0.87% |
-6.14% |
-16.23% |
|
0.12% |
8.22% |
-1.77% |
-4.70% |
6.48% |
1.23% |
-4.70% |
|
0.27% |
2.21% |
-9.98% |
-9.26% |
10.61% |
-5.59% |
-10.86% |
|
1.86% |
4.37% |
-6.56% |
-5.53% |
14.22% |
1.00% |
-6.67% |
|
0.32% |
2.29% |
-9.72% |
-8.66% |
12.16% |
-2.73% |
-10.25% |
|
-1.64% |
0.75% |
-13.57% |
-18.40% |
-8.50% |
-13.28% |
-18.85% |
|
-0.08% |
2.90% |
-10.25% |
-15.01% |
-5.51% |
-7.17% |
-15.00% |
|
-1.57% |
0.87% |
-13.28% |
-17.83% |
-7.20% |
-10.59% |
-18.26% |
|
-3.05% |
2.71% |
-10.24% |
-13.51% |
8.31% |
-6.62% |
-13.51% |
|
-3.71% |
3.33% |
-9.90% |
-18.00% |
-5.37% |
-7.63% |
-18.00% |
|
-0.39% |
7.20% |
-5.95% |
-8.17% |
6.53% |
2.85% |
-8.17% |
|
0.00% |
9.20% |
-7.77% |
-13.17% |
3.79% |
-1.93% |
-13.17% |
| 基金平均績效 |
-0.53% |
3.08% |
-9.05% |
-12.96% |
1.90% |
-4.27% |
-13.39% |
* 基金報酬率包含配息
(若未註明"*"，則基金報酬率不包含配息，對於有配息之基金，將造成總報酬率數值低估。)
本資訊僅供參考，實際數據以官方公佈資料為準。 本站自當盡力為使用者提供正確的意見及消息，但如有錯漏或疏忽，本站恕不負任何法律責任。
|
